The unprecedented rapid deployment of mRNA vaccines against COVID-19 can be traced back to the early studies of RNA nanocarriers, including the study by Zimmerman which showcased the effectiveness of RNA nanocarriers in vivo. This study, among others, ultimately resulted in Onpattro, the first FDA-approved RNA formulation.
- SEO Powered Content & PR Distribution. Get Amplified Today.
- Platoblockchain. Web3 Metaverse Intelligence. Knowledge Amplified. Access Here.
- Source: https://www.cell.com/trends/biotechnology/fulltext/S0167-7799(22)00347-X?rss=yes
More from Biotechnology Trends
Biotechnology and Biosafety Policy at OECD: Future Trends
Source Node: 802520
Time Stamp: Mar 19, 2021
Public acceptance and stakeholder views of gene edited foods: a global overview
Source Node: 1903120
Time Stamp: Jan 17, 2023
Tandem chemocatalysis and biological funneling to valorize lignin
Source Node: 1879654
Time Stamp: Dec 17, 2022
Biowaste upcycling into second-generation microbial protein through mixed-culture fermentation
Source Node: 1891861
Time Stamp: Aug 19, 2022
Insights into methanotroph carbon flux pave the way for methane biocatalysis
Source Node: 1924429
Time Stamp: Jan 27, 2023
In vivo protein-based biosensors: seeing metabolism in real time
Source Node: 1790356
Time Stamp: Dec 28, 2022
Machine learning in bioprocess development: from promise to practice
Source Node: 1783311
Time Stamp: Nov 28, 2022
Carbon-negative synthetic biology: challenges and emerging trends of cyanobacterial technology
Source Node: 1779603
Time Stamp: Dec 20, 2022
Synthetic biology for plant genetic engineering and molecular farming
Source Node: 2042801
Time Stamp: Mar 31, 2023